{
    "__type__": "Deck", 
    "children": [], 
    "crowdanki_uuid": "0aecb5c0-d637-11e7-8582-408d5c5c9416", 
    "deck_config_uuid": "0aecb5c1-d637-11e7-b61d-408d5c5c9416", 
    "deck_configurations": [
        {
            "__type__": "DeckConfig", 
            "autoplay": true, 
            "crowdanki_uuid": "0aecb5c1-d637-11e7-b61d-408d5c5c9416", 
            "dyn": false, 
            "lapse": {
                "delays": [
                    10
                ], 
                "leechAction": 0, 
                "leechFails": 8, 
                "minInt": 1, 
                "mult": 0
            }, 
            "maxTaken": 60, 
            "name": "Default", 
            "new": {
                "bury": true, 
                "delays": [
                    1, 
                    10
                ], 
                "initialFactor": 2500, 
                "ints": [
                    1, 
                    4, 
                    7
                ], 
                "order": 1, 
                "perDay": 20, 
                "separate": true
            }, 
            "replayq": true, 
            "rev": {
                "bury": true, 
                "ease4": 1.3, 
                "fuzz": 0.05, 
                "ivlFct": 1, 
                "maxIvl": 36500, 
                "minSpace": 1, 
                "perDay": 100
            }, 
            "timer": 0
        }
    ], 
    "desc": "", 
    "dyn": 0, 
    "extendNew": 10, 
    "extendRev": 50, 
    "media_files": [], 
    "mid": "1512116153364", 
    "name": "fracp-anki", 
    "note_models": [
        {
            "__type__": "NoteModel", 
            "crowdanki_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "css": ".card {\nfont-family: arial;\nfont-size: 16px;\nline-height: 1.4em;\ntext-align: left;\n color: #263238;\n background-color: #ECEFF1;\npadding: 20px;\n}\n\n.card-container{\nbackground-color: white;\npadding: 10px 15px 15px 15px;\nbox-shadow: 0 2px 2px 0 rgba(0,0,0,0.2);\nmargin-bottom: 20px;\nborder-radius: 2px;\n}\n\n.letter{\nfont-size: 20px;\ncolor:#37474F;\nmargin-bottom: 8px;\npadding-bottom: 8px;\nfont-family: Ebrima;\nborder-bottom: 1px solid #388E3C;\n}\n\nul{\n\tlist-style-position: inside;\n\tpadding-left: 0;\npadding-top: 0;\npadding-bottom: 0;\n}\n\n.references{\ncolor: #607D8B;\nfont-size: 14px;\n}", 
            "flds": [
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Question", 
                    "ord": 0, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Answer", 
                    "ord": 1, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }, 
                {
                    "font": "Arial", 
                    "media": [], 
                    "name": "Reference", 
                    "ord": 2, 
                    "rtl": false, 
                    "size": 12, 
                    "sticky": false
                }
            ], 
            "latexPost": "\\end{document}", 
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n", 
            "name": "FRACP Type", 
            "req": [
                [
                    0, 
                    "all", 
                    [
                        0
                    ]
                ]
            ], 
            "sortf": 0, 
            "tags": [
                "Cardiology"
            ], 
            "tmpls": [
                {
                    "afmt": "<div class=\"card-container\">\n<div class=\"letter\">Q.</div>\n{{Question}}\n</div>\n\n<div class=\"card-container\">\n<div class=\"letter\">A.</div>\n{{Answer}}\n</div>\n\n<div class=\"card-container references\">\n<div>{{Tags}}</div>\n<div>{{Reference}}</div>\n</div>\n", 
                    "bafmt": "", 
                    "bfont": "Arial", 
                    "bqfmt": "", 
                    "bsize": 12, 
                    "did": null, 
                    "name": "Card 1", 
                    "ord": 0, 
                    "qfmt": "<div class=\"card-container\">\n<div class=\"letter\">Q.</div>\n{{Question}}\n</div>"
                }
            ], 
            "type": 0, 
            "vers": []
        }
    ], 
    "notes": [
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 antianginal medications used in the management of stable angina.", 
                "<ul><li>ß-blockers</li><li>Nitrates</li><li>Calcium channel blockers</li><li>Ranolazine</li></ul>", 
                ""
            ], 
            "flags": 0, 
            "guid": "qz7,uLA)8e", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The COURAGE trial compared PCI + medical therapy vs. medical therapy alone as an initial management strategy in patients with stable ischaemic heart disease. What was the main conclusion of this trial?", 
                "Although the addition of PCI to optimal medical therapy reduced the prevalence of angina, it did not reduce long-term rates of death, nonfatal myocardial infarction, and hospitalization for acute coronary syndromes.", 
                "https://www.ncbi.nlm.nih.gov/pubmed/17387127"
            ], 
            "flags": 0, 
            "guid": "s(&yGZmQc@", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the only antianginal drug class proven to prevent reinfarction and to improve survival in patients who have sustained a myocardial infarction.", 
                "ß-blockers", 
                "https://www.ncbi.nlm.nih.gov/pubmed?term=8371471"
            ], 
            "flags": 0, 
            "guid": "kDEax2q{$r", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name an appropriate first line investigation for suspected stable ischaemic heart disease.", 
                "Cardiac stress testing", 
                ""
            ], 
            "flags": 0, 
            "guid": "qqa`li!;E]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of aspirin.", 
                "Irreversible inhibition of cyclooxygenase and thereby inhibiting the formation of eicosanoids (thromboxane A<sub>2</sub>) via the oxygenation of arachidonic acid.", 
                "https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/215618"
            ], 
            "flags": 0, 
            "guid": "BF>b>hG[t]", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The CURE trial tested the efficacy of prolonged aspirin + clopidogrel compared to aspirin alone in ACS without STEMI. What were the key findings?", 
                "<ul><li>Dual antiplatelet therapy with clopidogrel and aspirin reduced cardiovascular mortality, non-fatal myocardial infarction or stroke</li><li>Superiority persisted throughout the 12 month study</li><li>Higher rates of major and minor bleeding, but no increase in life-threatening bleeding or intracranial haemorrhage</li></ul>", 
                "https://www.ncbi.nlm.nih.gov/pubmed/11519503"
            ], 
            "flags": 0, 
            "guid": "kTU/W:~zaZ", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the recommended time frame in which a patient presenting with acute chest pain or suspected acute coronary syndrome should undergo an ECG?", 
                "10 minutes", 
                "National Heart Foundation of Australia &amp; Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016"
            ], 
            "flags": 0, 
            "guid": "zk:f):Lwzl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 contraindications to the use of nitrate therapy.", 
                "<ul style=\"margin-left: 20px; \"><li>Allergy</li><li>Hypotension (&lt;90)</li><li>Bradycardia (&lt;50)</li><li>Tachycardia (&gt;100)</li><li>Phosphodiesterase inhibitor within the previous 24 hours</li><li>Hypertrophic cardiomyopathy</li><li>Severe aortic stenosis</li></ul>", 
                "ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction"
            ], 
            "flags": 0, 
            "guid": "iv0T$[op/3", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of clopidogrel.", 
                "The active metabolite of the thienopyridines (clopidogrel, prasugrel) irreversibly binds to the platelet P2Y<sub>12</sub>&nbsp;receptor and inhibits platelet aggregation for the life of the platelet.", 
                "Australian Medicines Handbook"
            ], 
            "flags": 0, 
            "guid": "qV]MexO7Dl", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of ticagrelor.", 
                "Ticagrelor, a nuceloside analogue,&nbsp;<b>reversibly</b> inhibits the adenosine diphosphate (ADP) receptor P2Y<sub>12</sub>. The thienopyridines (clopidogrel, prasugrel) irreversibly inhibit P2Y<sub>12</sub>.", 
                ""
            ], 
            "flags": 0, 
            "guid": "wf$J875j)7", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The PLATO trial compared ticagrelor and clopidogrel in patients with acute coronary syndrome. What were the findings of this study?", 
                "<ul><li>Compared to clopidogrel, ticagrelor significantly reduced the rate of cardiovascular death, myocardial infarction, or stroke</li><li>Benefit &nbsp;persisted up to 12 months</li><li>No increase in overall major bleeding</li></ul>", 
                "https://www.ncbi.nlm.nih.gov/pubmed/19717846"
            ], 
            "flags": 0, 
            "guid": "J/Y5?d9ATR", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name &nbsp;indications for coronary angiography in patients with stable ischaemic heart disease (SIHD).", 
                "<ul style=\"margin-left: 20px; \"><li>Angina that significantly interferes with a patient's lifestyle despite maximal tolerable medical therapy</li><li>Patients with high-risk criteria (survivors of cardiac arrest</li></ul>", 
                ""
            ], 
            "flags": 0, 
            "guid": "ql~u/+/uOx", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the preferred first line antianginal for patients with stable ischaemic heart disease (SIHD).", 
                "ß-blocker", 
                ""
            ], 
            "flags": 0, 
            "guid": "s~}U_}vu6{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism by which sudden withdrawal of ß-blocker therapy may precipitate exacerbation of ischaemic symptoms, including myocardial infarction.", 
                "Chronic use of ß-blocker therapy results in upregulation of adrenergic receptor density, and consequent increase in responsiveness to circulating catecholamines.", 
                ""
            ], 
            "flags": 0, 
            "guid": "Es2n>Rl*<`", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 major determinants of myocardial oxygen demand.", 
                "Heart rate<div>Myocardial contractility</div><div>Myocardial wall tension</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "bwbW!=)aR/", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "During which phase of the cardiac cycle is the majority of blood delivered to the myocardium?", 
                "Diastole", 
                ""
            ], 
            "flags": 0, 
            "guid": "KSl.C;_X:l", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 3 vessel types which account for 75% of coronary blood flow resistance.", 
                "R1: Large epicardial arteries (trivial in the absence of IHD)<div>R2: Prearteriolar vessels</div><div>R3: Arteriolar and intra-myocardial capillary vessels</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "p,6>Mz~Z@,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 non-atherosclerotic causes that limit coronary blood flow.", 
                "Spasm<div>Arterial thrombi (e.g. due to procoagulative state)</div><div>Coronary emboli</div><div>Ostial narrowing due to aortitis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "kUtc$#HAf6", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the 5 major risk factors for coronary artery disease.", 
                "High LDL<div>Low HDL</div><div>Smoking</div><div>HTN</div><div>Diabetes</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "uWmoVg^O[z", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 components of athersclerotic plaque.", 
                "Fat<div>Smooth muscle cells</div><div>Fibroblasts</div><div>Intracellular matrix</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tg64xDG_Hs", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "At what degree of stenosis (%) does coronary luminal narrowing begin to limit the ability to increase flow to meet myocardial demand?", 
                "50%", 
                ""
            ], 
            "flags": 0, 
            "guid": "A$,b*m1ZvD", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe 2 processes which result in thrombus formation when an atherosclerotic plaque ruptures.", 
                "Platelet activation and aggregation<div>Activation of the coagulation cascade leading to deposition of fibrin strands</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "tDtz&m5OU#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In the event of coronary occlusion, which portion of the myocardium is most affected by ischaemia?", 
                "Subendocarium", 
                ""
            ], 
            "flags": 0, 
            "guid": "CE$K/4i_(R", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of mitral regurgitation in acute myocardial ischaemia.", 
                "Papillary muscle involvement in the setting of large left ventricular infarct", 
                ""
            ], 
            "flags": 0, 
            "guid": "FLX|6X+4W5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "After approximately what period of time does myocardial ischaemic damage become non-reversible?", 
                "20 minutes", 
                ""
            ], 
            "flags": 0, 
            "guid": "OT:9HyvO[#", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 6 biochemical events which occur in the event of myocardial ischaemia", 
                "Fatty acids unable to be oxidised<div>Metabolism of glucose to lactate, causing pH drop<div>Reduce myocardial stores of high energy phosphates (ATP)</div><div>Potassium leak</div><div>Uptake of sodium</div><div>Increase in cytosolic calium</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "BCo[$i#Nsv", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "ST elevation reflects ischaemia of what part of the myocardium?", 
                "Severe transmural ischaemia", 
                ""
            ], 
            "flags": 0, 
            "guid": "D$=NU95R}o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe Levine's sign.", 
                "A clenched fist held over the chest to describe angina.", 
                ""
            ], 
            "flags": 0, 
            "guid": "GJ%%:#ggf+", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe New York Heart Association class I functional status.", 
                "Patient has cardiac disease, but ordinary physical activity does not cause undue fatigue, palpitations, dyspnoea, or angina.", 
                ""
            ], 
            "flags": 0, 
            "guid": "x)-Bjm;t]G", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe New York Heart Association class II functional status.", 
                "Patient has cardiac disease resulting in slight limitation of physical activity.&nbsp;<div>Comfortable at rest.&nbsp;<div>Ordinary physical activity results in fatigue, palpitations, dyspnoea, or angina.</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pN<:/->=A^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe New York Heart Association class III functional status.", 
                "Patient has cardiac disease resulting in marked limiation of physical activity.<div>Comfortable at rest.</div><div>Less than ordinary physical activity causes fatigue, palpitations, dyspnoea, or angina.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "Q,0fX9p&;$", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe New York Heart Association class IV functional status.", 
                "Patient has cardiac disease resulting in inability to carry out any physical activity without discomfort.<div>Symptoms may be present at rest.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "xq>z12*CH5", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 blood investigations which may be ordered for a patient with suspected new stable ischaemic heart disease.", 
                "Lipid profile<div>HbA1c/fasting glucose</div><div>Renal function</div><div>Haemoglobin</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "sa.2Lp}ZI}", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What ECG findings constitute a positive stress ECG test?", 
                "<div>Flat or downsloping ST depression &gt;0.1mV</div><div><br /></div><div>The following are NOT considered diagnostic:</div>T wave abnormalities<div>Conduction abnormalities<br /><div><div>Upsloping or junctional ST segment changes</div><div>Ventricular arrythmias</div><div>Failure to reach 85% predicted heart rate</div></div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "At|h#B5Lv2", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 7 contraindications to exercise stress testing", 
                "<div>Rest angina within 48hours of the test</div>Unstable rhythm<div>Severe aortic stenosis</div><div>Acute myocarditis</div><div>Uncontrolled heart failure</div><div>Severe pulmonary hypertension</div><div>Active infective endocarditis</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "/~88({tV{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the sensitivity of exercise stress testing?", 
                "75% (a&nbsp;negative test does not exclude coronary artery disease).", 
                ""
            ], 
            "flags": 0, 
            "guid": "wS)EVJwqI^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Histologically, the first phase of atherosclerosis is characterised by the accumulation of what cell type within intima?", 
                "Lipid-laden macrophages (foam cells) are the hallmark of early atheroma.", 
                ""
            ], 
            "flags": 0, 
            "guid": "YRD?mAdfE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pathophysiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The thickening of the intima by accumulation of lipid-laden macrophages (foam cells) and extracellular matrix represents the first phase of atherosclerosis and is known by what term?", 
                "Fatty streaks", 
                ""
            ], 
            "flags": 0, 
            "guid": "lNy!+VT83?", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pathophysiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with suspected acute coronary syndrome, what is the recommendation regarding use of supplemental oxygen therapy?", 
                "Routine use of supplemental oxygen therapy for patient's with oxygen saturation &gt; 93% is not recommended.", 
                ""
            ], 
            "flags": 0, 
            "guid": "tr}tkpbJA,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Pathophysiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the recommended duration of dual antiplatelet therapy for patients who have undergone stenting for acute coronary syndrome.", 
                "12 months<div>It may be reasonable to continue dual antiplatelet therapy for greater than 12 months in patients who have a low bleeding risk</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "KkG0tzL>zS", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Approximately what percentage of patients with left main coronary artery disease will also have multivessel coronary artery disease?", 
                "70%", 
                ""
            ], 
            "flags": 0, 
            "guid": "jq!suB@etw", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "In patients with left main coronary disease with associated multivessel disease, what is the preferred revascularisation strategry?", 
                "Patients with significant left main coronary artery disease (≥50%) should undergo revascularisation with either CABG or PCI.<div>The preferred revascularisation strategy is CABG where possible.</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "pNn`0EyoEE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the preferred revascularisation strategry In patients with coronary artery disease with a ≥ 70% stenosis in ≥ 3 vessels, without proximal LAD involvement?", 
                "CABG", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pp12?~-%<o", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A \"small box\" on the ECG represents how many millimetres (mm), seconds or milivolts (mV)?", 
                "1mm<div>0.04 seconds</div><div>0.1mV</div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "O<Pdk~4?M;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "A narrow complex QRS complex on an ECG is defined as what duration of time/number of small boxes?", 
                "3 small boxes (small box = 0.04 seconds = 40 milliseconds)<div><div>120 milliseconds</div></div>", 
                ""
            ], 
            "flags": 0, 
            "guid": "r8XL5XRpl0", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The normal cardiac impulse in generated by pacemaker cells in what specialised area of the heart?", 
                "Sinoatrial node located at the juntion of the right atrium and superior vena cava.", 
                ""
            ], 
            "flags": 0, 
            "guid": "BcWf^ka0W%", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Physiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The p wave on an ECG represents depolarisation of what cardiac structures?", 
                "Right and left atrial depolarisation. The right atrium depolarises before the left atrium and represents the first part of the p wave.", 
                ""
            ], 
            "flags": 0, 
            "guid": "r$V~,1LTwI", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Physiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "First degree heart block is diagnoses by what finding on the ECG?", 
                "A PR interval greater than 200 milliseconds (5 \"small\" ECG squares).", 
                ""
            ], 
            "flags": 0, 
            "guid": "Pl)F}xYf<D", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Physiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The T wave on an ECG represents repolarisation of what cardiac structures?", 
                "Ventricular repoarisation is represented by a T wave (normally) of the same polarity as the QRS complex.", 
                ""
            ], 
            "flags": 0, 
            "guid": "nTOawSt]9D", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology", 
                "Physiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "What is the normal range of duration for the PR interval on an ECG?", 
                "120 milliseconds - 200 milliseconds (3 - 5 small squares)", 
                ""
            ], 
            "flags": 0, 
            "guid": "GAlG4CZxkE", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for heart failure with reduced ejection fraction (HFrEF).", 
                "<ul><li>Symptoms ± signs of heart failure</li><li>Left ventircular ejection fracture (LVEF) &lt; 40%</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "NyBe]3JvMH", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for heart failure with mildly reduced ejection fracture (HFmrEF).", 
                "<ul><li>Symptoms ± signs of heart failure</li><li>LVEF 40 - 49%</li><li>Elevated levels of natriuretic peptides</li><li>At least one additonal criterion:</li><ul><li>Relevant structural heart disease (left ventricular hypertrophy and/or left atrial enlargement)</li><li>Diastolic dysfunction</li></ul></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "d0},Em&j8T", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for heart failure with preserved ejection fraction (HFpEF).", 
                "<ul><li>Symptoms ± signs of heart failure</li><li>Left ventricular ejection fraction &gt; 50%</li><li>Elevated levels of natriuretic peptids</li><li>At least one additional criterion:</li><ul><li>Relevant structural heart disease (left ventricular hypertrophy and/or left atrial enlargement)<br /></li><li>Diastolic dysfunction</li></ul></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "e:8,EAr=hc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The Killip classification is a system used to stratify risk of death following acute myocardial infarction. What is Killip class I?", 
                "Individuals with no clinical signs of heart failure.", 
                ""
            ], 
            "flags": 0, 
            "guid": "xI,.^.$AK^", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 recreational substances which may cause heart failure.", 
                "<ul><li>Alcohol</li><li>Cocaine</li><li>Amphetamine</li><li>Anabolic steroids</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "hy+,k.6+&4", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 heavy metals which may cause heart failure.", 
                "<ul><li>Copper</li><li>Iron</li><li>Lead</li><li>Cobalt</li></ul>", 
                ""
            ], 
            "flags": 0, 
            "guid": "c#3+o|=d.U", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name the recommended technique for measurement of left ventricular ejection fraction using echocardiography.", 
                "Modified biplane Simpson's rule", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "g7(<g~3c&{", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 8 which should be considered in the initial assessment of a patient with newly diagnosed heart failure.", 
                "<ul><li>FBE</li><li>UEC</li><li>LFTs</li><li>Hba1c/fasting glucose</li><li>Lipid profile</li><li>TSH</li><li>Iron studies</li><li>Natriuretic peptics</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "jyr~Vtc~Ug", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 2 echocardiographic measurements which are important in determining right ventricular systolic function.", 
                "<ul style=\"margin-left: 20px; \"><li>Tricuspid annular plane systolic excursion</li><li>Tricuspid lateral annular systolic velocity</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "cC+>C->wK,", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 3 causes of heart failure where genetic testing is recommended.", 
                "<ul style=\"margin-left: 20px; \"><li>Hypertrophic cardiomyopathy (HCM)</li><li>Idiopathic dilated cardiomyopathy (DCM)</li><li>Arrhythmogenic right ventricular cardiomyopathy (ARVC)</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "y5K`eg:PB[", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "The SPRINT trial compared intensive blood pressure control (target systolic blood pressure &lt; 120 mm Hg) in patients at high risk for cardiovascular disease without stroke or diabetes to standard treatment (target systolic blood pressure 135 - 139 mm Hg). What were the key findings?", 
                "In patients at high risk for CVD (without previous stroke or diabetes), intensive BP control (target systolic blood pressure &lt;120mm Hg) improved cardiovascular outcomes and overall survival compared to standard therapy (target SBP 135 - 139mm Hg).", 
                "https://www.ncbi.nlm.nih.gov/pubmed/26551272"
            ], 
            "flags": 0, 
            "guid": "epu@[&:i4v", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the mechanism of action of empagliflozin.", 
                "Inhibition of&nbsp;sodium-glucose co-transporter 2", 
                "Australian Medicines Handbook"
            ], 
            "flags": 0, 
            "guid": "u~qTf>;-G~", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Endocrinology", 
                "Pharmacology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Name 4 treatments (or combination of treatments) that may cause harm in patients with symptomatic (NYHA Class II - IV) heart failure with reduced ejection fraction (HFrEF)", 
                "<ul style=\"margin-left: 20px; \"><li>Thiazolidinediones (glitazones)</li><li>NSAIDs or COX-2 inhibitors</li><li>Diltiazem or verapamil</li><li>Adding an ARB to an ACE-I + MRA (risk of hyperkalaemia and renal dysfunction)</li></ul>", 
                "https://academic.oup.com/eurheartj/article/37/27/2129/1748921"
            ], 
            "flags": 0, 
            "guid": "qemdtRQ>Dc", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Describe the universal definition of myocardial infarction.", 
                "A combination of criteria is required to meet the diagnosis of acute myocardial infarction:<div><ul style=\"margin-left: 20px; \"><li>Abnormal cardiac biomarker (value above 99th percentile reference limit)</li></ul><div>Plus at least one of the following:</div></div><div><ul style=\"margin-left: 20px; \"><li>Symptoms of ischaemia</li><li>New significant ST-T wave changes or left bundle branch block</li><li>Pathological Q waves</li><li>Imaging evidence of new loss of viable myocardium or regional wall motion abnormality</li><li>Intracoronary thrombus detected on angiography or autopsy</li></ul></div>", 
                "https://academic.oup.com/eurheartj/article/37/3/267/2466099"
            ], 
            "flags": 0, 
            "guid": "ksVT,9e:5>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for type 1 myocardial infarction.", 
                "Myocardial necrosis due to disruption of an atherosclerotic plaque, consequent intraluminal thrombus and reduced myocardial blood flow.", 
                "https://academic.oup.com/eurheartj/article/37/3/267/2466099"
            ], 
            "flags": 0, 
            "guid": "h+lZaCOha;", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }, 
        {
            "__type__": "Note", 
            "data": "", 
            "fields": [
                "Give a definition for type 2 myocardial infarction.", 
                "Myocardial necrosis in which a condition other than coronary plaque disruption results in an imbalance between myocardial oxygen supply and demand. Mechanisms include tachyarrythmias, coronary artery spasm, anaemia, etc.", 
                "https://academic.oup.com/eurheartj/article/37/3/267/2466099"
            ], 
            "flags": 0, 
            "guid": "PV.qw~m&O>", 
            "note_model_uuid": "0aecb5c4-d637-11e7-8e91-408d5c5c9416", 
            "tags": [
                "Cardiology"
            ]
        }
    ]
}